Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study of INCMGA00012 in Combination With Other Therapies in Patients With Advanced Solid Tumors

NCT03589651 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT03589651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03589651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study of INCMGA00012 in Combination With Other Therapies in Patients With Advanced Solid Tumors
Lead sponsor
Incyte Corporation
Phase
Phase 1
Overall status
Completed
Start date
August 17, 2018
Completion date
November 21, 2022
Enrollment
83 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

unresectable or metastatic solid tumors